ASKA Pharmaceutical Holdings Co., Ltd.(JP:4886)
¥2,149.00+26.00 (+1.22%)
JP:4886
ASKA Pharmaceutical Holdings Co., Ltd. Revenue
¥2,149.00
At close:+26.00 (+1.22%)
Want to see JP:4886 full AI Analyst Report?
ASKA Pharmaceutical Holdings Co., Ltd. (4886) Revenue
0 Followers
ASKA Pharmaceutical Holdings Co., Ltd. Revenue
ASKA Pharmaceutical Holdings Co., Ltd. had a revenue of 17.38B in the quarter ending Jun 30, 2026, with 4.46%. This bring the company's revenue in the last twelve months to 70.87B, Decreased 0.36%. In the fiscal year ending Mar 31, 2026, ASKA Pharmaceutical Holdings Co., Ltd. had annual revenue of 71.13B with 10.90% growth.
- Revenue (ttm)
- 70.87B
- Revenue Growth
- ―
- P/S Ratio
- 0.79
- Revenue/Employee
- JPY 44,150,838
- Employees
- 1,611
- Market Cap
- JPY 56.50B
Revenue Chart
ASKA Pharmaceutical Holdings Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 71.13B | 6.99B | 10.90% |
| Mar 31, 2025 | 64.14B | 1.30B | 2.06% |
| Mar 31, 2024 | 62.84B | 2.38B | 3.94% |
| Mar 31, 2023 | 60.46B | 3.85B | 6.81% |
| Mar 31, 2022 | 56.61B | 1.43B | 2.58% |
| Mar 31, 2021 | 55.18B | 2.64B | 5.02% |
| Mar 31, 2020 | 52.54B | 5.84B | 12.50% |
| Mar 31, 2019 | 46.70B | -2.24B | -4.57% |
| Mar 31, 2018 | 48.94B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.